The coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil, and South Africa, and a vaccine expert from the Médecins Sans Frontières (MSF or Doctors Without Borders) Access Campaign published a report today identifying over 100 companies in Africa, Asia, and Latin America with the potential to produce mRNA vaccines for the Covid-19 response. Human Rights Watch wrote to the US and German governments urging them to act on this research. The Human Rights Watch European media director, Andrew Stroehlein, sat down (virtually) with the report’s co-author, Achal Prabhala*, to discuss the findings and methodology. Prabhala also described what should now happen to expand vaccine production globally, so we can fight the virus more effectively.